ArticleCureus2025
Folic Acid and Pregnancy: Assessing Awareness, Timing, and Use of Folic Acid Among Pregnant Women in Medinah, Kingdom of Saudi Arabia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFolic acid (FA) plays a crucial role in the prevention of neural tube defects (NTDs) and other congenital anomalies during fetal development. Despite the known benefits, awareness and proper utilization of FA among pregnant women remain inconsistent globally.
objectiveThe overall objective of this study was to assess the awareness and practices related to FA use during pregnancy among Saudi women attending antenatal care clinics in Medinah, Saudi Arabia.
methodsA cross-sectional study was conducted from October to December 2024 at selected antenatal clinics across the primary healthcare centers and the maternity hospitals in Medinah. A total of 400 Saudi pregnant women were recruited using a cluster sampling technique. Data were collected using a structured, validated questionnaire administered via face-to-face interviews. Descriptive statistics, Mann-Whitney Z-test, and Kruskal-Wallis H-test were used to analyze the data with IBM SPSS Statistics for Windows, version 26 (IBM Corp., Armonk, New York, United States). A p-value of <0.05 was considered statistically significant.
resultsAmong the 400 participants, 194 (48.5%) were aged 31-40 years, 182 (45.5%) held a bachelor's degree, and 306 (76.5%) were housewives. A total of 394 (98.5%) reported using FA during pregnancy, but only 76 (19.0%) correctly identified it as a vitamin. Additionally, 215 (53.8%) recognized its role in preventing neural tube defects. Awareness regarding the appropriate timing of FA intake was 283 (70.8%) for the first trimester and 175 (43.8%) for starting three months before pregnancy.
conclusionAlthough most pregnant women reported taking FA, there were notable gaps in their knowledge regarding its classification and proper timing of intake. These findings indicated the need for targeted educational campaigns through tailored health education programs, social platforms, and community-based programs to enhance awareness toward the importance of taking FA before and during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.